These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12852343)

  • 41. Prophylaxis of hepatitis B recurrence in post-liver transplantation patients with lamivudine-resistant YMDD mutant.
    Yang Y; Zhang Q; Cai CJ; Lu MQ; Li X; Jiang N; Jiang H; Xu C; Li H; Wang GS; Yi SH; Zhang J; Zhang JF; Yi HM; Zhang YC; Chen GH
    Chin Med J (Engl); 2007 Aug; 120(16):1400-3. PubMed ID: 17825167
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HBV disease: HBsAg carrier and occult B infection reactivation in haematological setting.
    Marinone C; Mestriner M
    Dig Liver Dis; 2011 Jan; 43 Suppl 1():S49-56. PubMed ID: 21195372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of recurrent hepatitis B infection in liver transplant recipients.
    Terrault NA
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S74-81. PubMed ID: 12362303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of lamivudine in the reactivation of hepatitis B virus infection in immunodepressed patients.
    Martín E; Rendón P; De Diego L; Soria MJ; Martínez MC; Martín L
    Rev Esp Enferm Dig; 2003 Nov; 95(11):804-8, 799-803. PubMed ID: 14640878
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Successful treatment with lamivudine for reactivated hepatitis B infection following chemotherapy for non-Hodgkin's lymphoma.
    Stroffolini T; Andriani A; Bibas M; Barlattani A
    Ann Hematol; 2002 Jan; 81(1):48-9. PubMed ID: 11807636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy.
    Koo YX; Tan DS; Tan IB; Tao M; Chow WC; Lim ST
    Cancer; 2010 Jan; 116(1):115-21. PubMed ID: 19899164
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress].
    Acar A; Görenek L; Aydin A; Eyigün CP; Eken A; Sayal A; Pahsa A
    Mikrobiyol Bul; 2009 Jul; 43(3):411-23. PubMed ID: 19795616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.
    Han SH; Ofman J; Holt C; King K; Kunder G; Chen P; Dawson S; Goldstein L; Yersiz H; Farmer DG; Ghobrial RM; Busuttil RW; Martin P
    Liver Transpl; 2000 Nov; 6(6):741-8. PubMed ID: 11084061
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients.
    Yeo W; Ho WM; Hui P; Chan PK; Lam KC; Lee JJ; Johnson PJ
    Breast Cancer Res Treat; 2004 Dec; 88(3):209-15. PubMed ID: 15609123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of immunosuppression and chemotherapy on reactivation of viral hepatitis.
    Fallahian F; Alavian SM; Fallahian V; Zamani F
    Saudi J Kidney Dis Transpl; 2010 Jul; 21(4):621-7. PubMed ID: 20587863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiviral treatment for chronic hepatitis B virus infection--immune modulation or viral suppression?
    Buster EH; Janssen HL
    Neth J Med; 2006 Jun; 64(6):175-85. PubMed ID: 16788215
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma.
    Li YH; He YF; Jiang WQ; Wang FH; Lin XB; Zhang L; Xia ZJ; Sun XF; Huang HQ; Lin TY; He YJ; Guan ZZ
    Cancer; 2006 Mar; 106(6):1320-5. PubMed ID: 16470607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administration.
    Dai MS; Wu PF; Shyu RY; Lu JJ; Chao TY
    Liver Int; 2004 Dec; 24(6):540-6. PubMed ID: 15566502
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hematologic safety of breast cancer chemotherapies in patients with hepatitis B or C virus infection.
    Shoji H; Hashimoto K; Kodaira M; Yunokawa M; Yonemori K; Shimizu C; Tamura K; Ando M; Fujiwara Y
    Oncology; 2012; 82(4):228-33. PubMed ID: 22508294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Liver in Oncology.
    Dhanasekaran R; Kwo PY
    Clin Liver Dis; 2017 Nov; 21(4):697-707. PubMed ID: 28987257
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of SAMe in chemotherapy-induced liver injury.
    Vincenzi B; Russo A; Terenzio A; Galvano A; Santini D; Vorini F; Antonelli-Incalzi R; Vespasiani-Gentilucci U; Tonini G
    Crit Rev Oncol Hematol; 2018 Oct; 130():70-77. PubMed ID: 30196914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Failure of long-term lamivudine prophylaxis in patients with resolved hepatitis B infection undergoing chemotherapy and allogenic hematopoietic stem cell transplantation for hematological malignancies: two case reports.
    Grossi G; Viganò M; Facchetti F; Labanca S; Loglio A; Dodero A; Montefusco V; Corradini P; Cafro A; Cairoli R; Colombo M; Lampertico P
    Haematologica; 2017 Oct; 102(10):e423-e426. PubMed ID: 28659333
    [No Abstract]   [Full Text] [Related]  

  • 58. Hepatotoxicity of chemotherapy.
    King PD; Perry MC
    Oncologist; 2001; 6(2):162-76. PubMed ID: 11306728
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatotoxicity of targeted therapy for cancer.
    Lee KW; Chan SL
    Expert Opin Drug Metab Toxicol; 2016 Jul; 12(7):789-802. PubMed ID: 27187715
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis B and C infection in children undergoing chemotherapy or bone marrow transplantation.
    Gigliotti AR; Fioredda F; Giacchino R
    J Pediatr Hematol Oncol; 2003 Mar; 25(3):184-92. PubMed ID: 12621235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.